Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20551 AL 20565

Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS

Szabo MP, Iba M, Nath A, Masliah E, Kim C.

Exp Mol Med. 2022 Apr;54(4):447-454. doi: 10.1038/s12276-022-00755-7. Epub 2022 Apr 8.

Potential Protein Blood-based Biomarkers in Different Types of Dementia: A Therapeutic Overview

Manzine PR, Vatanabe IP, Grigoli MM, Pedroso RV, Monteiro MPAO, Oliveira DSMS, Nascimento CMC, Peron R, Orlandi FS, Cominetti MR.

Curr Pharm Des. 2022;28(14):1170-1186. doi: 10.2174/1381612828666220408124809.

Pseudobulbar affect in neurodegenerative diseases: A systematic review and meta-analysis

Nabizadeh F, Nikfarjam M, Azami M, Sharifkazemi H, Sodeifian F.

J Clin Neurosci. 2022 Jun;100:100-107. doi: 10.1016/j.jocn.2022.04.009. Epub 2022 Apr 15.

Research progress on the role and regulatory mechanism of pathogenic Th17 cells in neuroinflammation

Dai HY, Ji D, Tan C, Sun J, Yao H.

Yi Chuan. 2022 Apr 20;44(4):289-299. doi: 10.16288/j.yczz.22-030.

Influencing factors and characterization methods of nanoparticles regulating amyloid aggregation

Li L, Liu J, Li X, Tang Y, Shi C, Zhang X, Cui Y, Wang L, Xu W.

Soft Matter. 2022 May 4;18(17):3278-3290. doi: 10.1039/d1sm01704g.

Alzheimer's Disease-Related Psychosis: An Overview of Clinical Manifestations, Pathogenesis, and Current Treatment

Benmelouka AY, Ouerdane Y, Outani O, Alnasser YT, Alghamdi BS, Perveen A, Ashraf GM, Ebada MA.

Curr Alzheimer Res. 2022;19(4):285-301. doi: 10.2174/1567205019666220418151914.

Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases

Sengupta U, Kayed R.

Prog Neurobiol. 2022 Jul;214:102270. doi: 10.1016/j.pneurobio.2022.102270. Epub 2022 Apr 18.

Parkin as a Molecular Bridge Linking Alzheimer's and Parkinson's Diseases?

Checler F, Alves da Costa C.

Biomolecules. 2022 Apr 9;12(4):559. doi: 10.3390/biom12040559.

The role of Th17 cells/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A

Fu J, Huang Y, Bao T, Liu C, Liu X, Chen X.

J Neuroinflammation. 2022 Apr 22;19(1):98. doi: 10.1186/s12974-022-02446-6.

Molecular interaction of stress granules with Tau and autophagy in Alzheimer's disease

Yu QY, Ye LQ, Li HL.

Neurochem Int. 2022 Jul;157:105342. doi: 10.1016/j.neuint.2022.105342. Epub 2022 Apr 21.

Gut Microbiota Interact With the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging

Mou Y, Du Y, Zhou L, Yue J, Hu X, Liu Y, Chen S, Lin X, Zhang G, Xiao H, Dong B.

Front Immunol. 2022 Apr 7;13:796288. doi: 10.3389/fimmu.2022.796288. eCollection 2022.

The Boston Process Approach and Digital Neuropsychological Assessment: Past Research and Future Directions

Libon DJ, Swenson R, Lamar M, Price CC, Baliga G, Pascual-Leone A, Au R, Cosentino S, Andersen SL.

J Alzheimers Dis. 2022;87(4):1419-1432. doi: 10.3233/JAD-220096.

Targeting Insulin-Like Growth Factor-I in Management of Neurological Disorders

Makkar R, Behl T, Sehgal A, Singh S, Sharma N, Makeen HA, Albratty M, Alhazmi HA, Meraya AM.

Neurotox Res. 2022 Jun;40(3):874-883. doi: 10.1007/s12640-022-00513-7. Epub 2022 Apr 27.

'Fly-ing' from rare to common neurodegenerative disease mechanisms

Ma M, Moulton MJ, Lu S, Bellen HJ.

Trends Genet. 2022 Sep;38(9):972-984. doi: 10.1016/j.tig.2022.03.018. Epub 2022 Apr 25.

Biomarkers and diagnosis of dementia with Lewy bodies including prodromal: Practical aspects

Blanc F, Bousiges O.

Rev Neurol (Paris). 2022 May;178(5):472-483. doi: 10.1016/j.neurol.2022.03.008. Epub 2022 Apr 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias